Exhibit 4.4 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT"), OR ANY APPLICABLE STATE SECURITIES LAWS. AND MAY NOT BE SOLD OR TRANSFERRED UNLESS SUCH SALE OR TRANSFER IS IN ACCORDANCE WITH THE...Rigel Pharmaceuticals Inc • September 15th, 2000 • Services-commercial physical & biological research • California
RECITALSLicense Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • California
Exhibit 4.2 RIGEL PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT TABLE OF CONTENTSRights Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • California
X = Y (A-B) ------- ARigel Pharmaceuticals Inc • September 15th, 2000 • Services-commercial physical & biological research • California
RECITALSIndemnity Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
RECITALSCollaboration Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
4. NET ISSUE ELECTION. The Holder may elect to receive, without the payment by the Holder of any additional consideration, shares of Preferred Stock equal to the value of this Warrant or any portion hereof by the surrender of this Warrant or such...Rigel Pharmaceuticals Inc • September 15th, 2000 • Services-commercial physical & biological research • California
EXHIBIT 10.7 COLLABORATIVE RESEARCH AND LICENSE AGREEMENT THIS COLLABORATIVE RESEARCH AND LICENSE AGREEMENT ("the Agreement") is entered into as of January 31, 1999 ("Effective Date") by and between PFIZER INC, a Delaware corporation, having an office...Collaborative Research and License Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • New York
EXHIBIT 10.3 RIGEL PHARMACEUTICALS, INC. 2000 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (INCENTIVE AND NONSTATUTORY STOCK OPTIONS) Pursuant to your Stock Option Grant Notice ("Grant Notice") and this Stock Option Agreement, RIGEL PHARMACEUTICALS,...Rigel Pharmaceuticals Inc • September 15th, 2000 • Services-commercial physical & biological research
RECITALSCollaborative Research and Development Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • California
RIGEL PHARMACEUTICALS 24 WINDSOR DRIVE, HILLSBOROUGH. CA 94010 PHONE/FAX: 415-579-4638Employment Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • California
Rigel Pharmaceuticals, Inc. (the "Company") is pleased to offer you the position of Vice President Research and Chief Operating Officer of the Company beginning January 16, 1997 ("Effective Date") on the terms set forth below (the "Agreement").
